Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

713
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
713
Neural Regulation01:37

Neural Regulation

40.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accelerating scientific discovery with Co-Scientist.

ArXiv·2026
Same author

Bridging the global Parkinson's divide: Technology as a structural solution for equitable and brain health-integrated care.

Journal of Parkinson's disease·2026
Same author

Origins of Size-Dependent Kinetics in Microdroplets.

The journal of physical chemistry letters·2026
Same author

Prediction of α-synuclein seed amplification assay positivity in remotely followed <i>LRRK2</i> G2019S carriers using a validated data-driven model.

Journal of clinical and translational science·2026
Same author

Patient-Reported Symptom Burden in Individuals With Parkinson Disease.

Neurology. Clinical practice·2026
Same author

Structural Lipidomics Uncovers CC Location-Specific Lipid Signatures and the Response to Immune Checkpoint Inhibitor in dMMR/MSI‑H Colorectal Cancer.

ACS measurement science au·2026

Related Experiment Video

Updated: Sep 15, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K

Remote AI Screening for Parkinson's Disease: A Multimodal, Cross-Setting Validation Study.

Md Saiful Islam1,2, Tariq Adnan1,2, Abdelrahman Abdelkader1

  • 1Department of Computer Science, University of Rochester, Rochester, New York, United States.

Research Square
|July 18, 2025
PubMed
Summary

PARK, an AI tool, remotely screens for Parkinson's disease (PD) using webcam data. It shows high accuracy in identifying PD, offering accessible screening for underserved populations.

Keywords:
AI screeningParkinsonian disordersParkinson’s diseaseartificial intelligencehome assessmentmovement disordersremote assessment

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.9K

Related Experiment Videos

Last Updated: Sep 15, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

3.9K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Digital Health

Background:

  • Parkinson's disease (PD) diagnosis often relies on specialized clinical assessments, which can be inaccessible.
  • Remote screening tools are needed to improve early detection and accessibility.

Purpose of the Study:

  • To evaluate the performance and usability of PARK, a web-based AI tool for remote Parkinson's disease screening.
  • To assess PARK's accuracy and generalizability across diverse populations and settings.

Main Methods:

  • Utilized video and audio recordings of speech, facial expression, and motor tasks from 1,865 participants.
  • Trained and validated the AI model on independent test sets (n=389) and compared performance with movement disorder specialists.
  • Conducted usability studies to assess participant satisfaction and preference.

Main Results:

  • PARK achieved high accuracy (80.2%-80.6%) and AUROC (0.85-0.87) in classifying individuals with and without PD.
  • Demonstrated strong agreement with clinical specialists and generalized well across demographic subgroups.
  • Usability studies reported high participant satisfaction and preference for remote screening.

Conclusions:

  • PARK shows potential as an accessible, scalable, and clinically aligned tool for remote Parkinson's disease identification.
  • The tool can support early detection, especially where traditional healthcare access is limited.
  • AI-powered remote screening offers a promising approach to overcome healthcare access barriers for neurological conditions.